Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 32 | 2022 | 441 | 4.560 |
Why?
|
| Lasers, Solid-State | 7 | 2025 | 23 | 3.480 |
Why?
|
| Lithotripsy, Laser | 6 | 2025 | 16 | 2.790 |
Why?
|
| Laser Therapy | 7 | 2022 | 243 | 2.250 |
Why?
|
| Lithotripsy | 3 | 2023 | 22 | 1.600 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2022 | 229 | 1.510 |
Why?
|
| Graphite | 3 | 2019 | 16 | 1.230 |
Why?
|
| Scattering, Radiation | 10 | 2026 | 52 | 1.190 |
Why?
|
| Lasers | 9 | 2025 | 111 | 1.170 |
Why?
|
| Neurofibroma | 2 | 2026 | 9 | 1.150 |
Why?
|
| Neurofibromatosis 1 | 2 | 2026 | 73 | 1.070 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 67 | 1.060 |
Why?
|
| Lasers, Semiconductor | 1 | 2025 | 8 | 0.900 |
Why?
|
| Kidney Calculi | 1 | 2025 | 42 | 0.850 |
Why?
|
| Coronary Vessels | 8 | 2023 | 521 | 0.840 |
Why?
|
| Refractometry | 4 | 2015 | 9 | 0.800 |
Why?
|
| Port-Wine Stain | 2 | 2022 | 10 | 0.780 |
Why?
|
| Cartilage | 6 | 2006 | 52 | 0.770 |
Why?
|
| Algorithms | 12 | 2016 | 1680 | 0.740 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2016 | 150 | 0.710 |
Why?
|
| Phantoms, Imaging | 9 | 2025 | 142 | 0.710 |
Why?
|
| Calculi | 1 | 2021 | 12 | 0.700 |
Why?
|
| Skin Neoplasms | 2 | 2026 | 909 | 0.670 |
Why?
|
| Optics and Photonics | 4 | 2019 | 107 | 0.650 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1306 | 0.650 |
Why?
|
| Doxorubicin | 2 | 2019 | 288 | 0.610 |
Why?
|
| Microvessels | 2 | 2021 | 58 | 0.540 |
Why?
|
| Liposomes | 2 | 2019 | 201 | 0.530 |
Why?
|
| Birefringence | 6 | 2012 | 10 | 0.520 |
Why?
|
| Light | 12 | 2016 | 166 | 0.520 |
Why?
|
| Photochemotherapy | 1 | 2017 | 39 | 0.520 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 123 | 0.500 |
Why?
|
| Nanoparticles | 2 | 2018 | 310 | 0.490 |
Why?
|
| Retinal Ganglion Cells | 4 | 2014 | 96 | 0.480 |
Why?
|
| Thulium | 3 | 2025 | 12 | 0.470 |
Why?
|
| Models, Theoretical | 2 | 2015 | 362 | 0.460 |
Why?
|
| Optic Nerve | 3 | 2014 | 110 | 0.450 |
Why?
|
| Retina | 3 | 2013 | 425 | 0.450 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 55 | 0.450 |
Why?
|
| Glioblastoma | 1 | 2019 | 371 | 0.440 |
Why?
|
| Nerve Fibers | 5 | 2014 | 65 | 0.430 |
Why?
|
| Hyperthermia, Induced | 3 | 2019 | 50 | 0.430 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 109 | 0.410 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2013 | 119 | 0.410 |
Why?
|
| Retinal Neurons | 1 | 2014 | 14 | 0.410 |
Why?
|
| Optic Disk | 3 | 2014 | 44 | 0.390 |
Why?
|
| Holmium | 3 | 2022 | 10 | 0.380 |
Why?
|
| Hot Temperature | 6 | 2025 | 137 | 0.380 |
Why?
|
| Skin | 5 | 2026 | 545 | 0.380 |
Why?
|
| Vascular Calcification | 2 | 2023 | 70 | 0.380 |
Why?
|
| Microscopy, Polarization | 2 | 2009 | 7 | 0.360 |
Why?
|
| Oximetry | 1 | 2013 | 176 | 0.350 |
Why?
|
| Humans | 45 | 2026 | 131163 | 0.350 |
Why?
|
| Image Enhancement | 3 | 2009 | 159 | 0.340 |
Why?
|
| Nephelometry and Turbidimetry | 2 | 2015 | 8 | 0.340 |
Why?
|
| Retinal Vessels | 1 | 2011 | 48 | 0.330 |
Why?
|
| Animals | 24 | 2022 | 33912 | 0.320 |
Why?
|
| Urinary Calculi | 2 | 2025 | 16 | 0.310 |
Why?
|
| Models, Biological | 4 | 2017 | 1371 | 0.300 |
Why?
|
| Oxygen | 1 | 2013 | 548 | 0.300 |
Why?
|
| Swine | 9 | 2022 | 1186 | 0.270 |
Why?
|
| Femoral Artery | 2 | 2019 | 134 | 0.270 |
Why?
|
| Tomography | 2 | 2004 | 32 | 0.260 |
Why?
|
| Ultrasonography | 3 | 2026 | 943 | 0.250 |
Why?
|
| Early Diagnosis | 2 | 2026 | 195 | 0.250 |
Why?
|
| Cornea | 1 | 2011 | 569 | 0.250 |
Why?
|
| Renal Artery | 1 | 2006 | 74 | 0.240 |
Why?
|
| Connective Tissue | 1 | 2006 | 26 | 0.240 |
Why?
|
| Blood Vessels | 2 | 2022 | 92 | 0.230 |
Why?
|
| Equipment Design | 5 | 2015 | 512 | 0.220 |
Why?
|
| Computer Simulation | 4 | 2025 | 674 | 0.220 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 27 | 0.220 |
Why?
|
| Therapeutic Irrigation | 1 | 2025 | 45 | 0.220 |
Why?
|
| Low-Level Light Therapy | 1 | 2005 | 19 | 0.220 |
Why?
|
| Blood Flow Velocity | 2 | 2022 | 417 | 0.220 |
Why?
|
| In Vitro Techniques | 4 | 2015 | 808 | 0.220 |
Why?
|
| Phototherapy | 2 | 2019 | 37 | 0.210 |
Why?
|
| Peripheral Arterial Disease | 2 | 2019 | 326 | 0.210 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 2085 | 0.210 |
Why?
|
| Microscopy, Interference | 1 | 2004 | 5 | 0.210 |
Why?
|
| Fractures, Stress | 1 | 2023 | 14 | 0.200 |
Why?
|
| Fourier Analysis | 2 | 2015 | 55 | 0.200 |
Why?
|
| Cardiologists | 1 | 2023 | 26 | 0.200 |
Why?
|
| Interferometry | 1 | 2003 | 21 | 0.190 |
Why?
|
| Erbium | 1 | 2022 | 3 | 0.190 |
Why?
|
| Bacillus subtilis | 1 | 2022 | 42 | 0.190 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 2904 | 0.180 |
Why?
|
| Temperature | 3 | 2017 | 291 | 0.180 |
Why?
|
| Osteoarthritis | 1 | 2004 | 105 | 0.180 |
Why?
|
| Glaucoma | 2 | 2014 | 73 | 0.180 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 2015 | 13 | 0.180 |
Why?
|
| Hemostasis | 1 | 2022 | 77 | 0.180 |
Why?
|
| Optic Nerve Diseases | 2 | 2014 | 76 | 0.170 |
Why?
|
| Neointima | 3 | 2019 | 48 | 0.170 |
Why?
|
| Arteries | 1 | 2003 | 208 | 0.170 |
Why?
|
| Mice | 5 | 2022 | 18301 | 0.170 |
Why?
|
| Blood Coagulation | 1 | 2022 | 134 | 0.170 |
Why?
|
| Biopsy | 2 | 2022 | 1239 | 0.170 |
Why?
|
| Laser Coagulation | 1 | 2022 | 114 | 0.170 |
Why?
|
| Fluorescein Angiography | 1 | 2021 | 63 | 0.170 |
Why?
|
| HMGB1 Protein | 1 | 2021 | 30 | 0.170 |
Why?
|
| Macrophages | 2 | 2015 | 667 | 0.160 |
Why?
|
| Angiography | 1 | 2021 | 179 | 0.160 |
Why?
|
| Infrared Rays | 3 | 2017 | 19 | 0.160 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 79 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 357 | 0.150 |
Why?
|
| Biomedical Engineering | 1 | 2019 | 21 | 0.150 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 10 | 0.150 |
Why?
|
| Materials Testing | 2 | 2018 | 73 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 305 | 0.150 |
Why?
|
| Biotechnology | 1 | 2019 | 59 | 0.150 |
Why?
|
| Quantum Dots | 1 | 2019 | 16 | 0.150 |
Why?
|
| Vascular Patency | 1 | 2019 | 185 | 0.140 |
Why?
|
| Paclitaxel | 1 | 2019 | 130 | 0.140 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 67 | 0.140 |
Why?
|
| Absorption, Physicochemical | 1 | 2018 | 3 | 0.140 |
Why?
|
| Radiometry | 4 | 2008 | 49 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 587 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 887 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 255 | 0.140 |
Why?
|
| Water | 2 | 2018 | 186 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2019 | 263 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 358 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 88 | 0.140 |
Why?
|
| Models, Cardiovascular | 3 | 2014 | 165 | 0.140 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 122 | 0.140 |
Why?
|
| Particle Size | 1 | 2018 | 135 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2019 | 365 | 0.140 |
Why?
|
| Endovascular Procedures | 2 | 2018 | 802 | 0.140 |
Why?
|
| Thermogravimetry | 1 | 2017 | 5 | 0.130 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2017 | 7 | 0.130 |
Why?
|
| Oxides | 1 | 2017 | 16 | 0.130 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 43 | 0.130 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2017 | 40 | 0.130 |
Why?
|
| Static Electricity | 1 | 2017 | 44 | 0.130 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 115 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 129 | 0.130 |
Why?
|
| Young Adult | 3 | 2026 | 10103 | 0.130 |
Why?
|
| Biological Availability | 1 | 2017 | 136 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4697 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2017 | 124 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 2602 | 0.120 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 2304 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 437 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2017 | 394 | 0.120 |
Why?
|
| Aspirin | 1 | 2018 | 211 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 713 | 0.120 |
Why?
|
| Macaca mulatta | 3 | 2012 | 504 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 267 | 0.120 |
Why?
|
| Angina, Stable | 1 | 2015 | 8 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2017 | 765 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 740 | 0.110 |
Why?
|
| Stents | 3 | 2018 | 799 | 0.110 |
Why?
|
| Aged | 8 | 2019 | 21025 | 0.110 |
Why?
|
| Female | 13 | 2026 | 70963 | 0.110 |
Why?
|
| Middle Aged | 10 | 2019 | 28601 | 0.110 |
Why?
|
| Metals | 1 | 2014 | 70 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2014 | 19 | 0.100 |
Why?
|
| Male | 13 | 2026 | 64957 | 0.100 |
Why?
|
| Artifacts | 1 | 2014 | 100 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1928 | 0.100 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2004 | 23 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3748 | 0.100 |
Why?
|
| Oxyhemoglobins | 1 | 2013 | 25 | 0.100 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2013 | 44 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 3016 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 499 | 0.100 |
Why?
|
| Electric Stimulation | 2 | 2004 | 234 | 0.090 |
Why?
|
| Adult | 5 | 2026 | 31282 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 878 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 235 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2004 | 483 | 0.090 |
Why?
|
| Time Factors | 6 | 2019 | 6196 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1489 | 0.090 |
Why?
|
| Basement Membrane | 1 | 2011 | 41 | 0.090 |
Why?
|
| Scanning Laser Polarimetry | 1 | 2011 | 2 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2020 | 1445 | 0.080 |
Why?
|
| Axons | 1 | 2014 | 386 | 0.080 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 299 | 0.080 |
Why?
|
| Brain | 1 | 2022 | 3175 | 0.080 |
Why?
|
| Succinates | 1 | 2010 | 14 | 0.080 |
Why?
|
| Rats | 2 | 2009 | 3370 | 0.080 |
Why?
|
| Soot | 1 | 2010 | 14 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 31 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 744 | 0.080 |
Why?
|
| X-Ray Microtomography | 2 | 2023 | 101 | 0.080 |
Why?
|
| Calcium | 2 | 2023 | 1010 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12936 | 0.070 |
Why?
|
| Skin Temperature | 1 | 2007 | 17 | 0.070 |
Why?
|
| Gold | 1 | 2008 | 53 | 0.070 |
Why?
|
| Adolescent | 1 | 2026 | 20987 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2007 | 132 | 0.060 |
Why?
|
| Elastin | 1 | 2006 | 32 | 0.060 |
Why?
|
| United States | 2 | 2019 | 12072 | 0.060 |
Why?
|
| Intervertebral Disc | 1 | 2006 | 13 | 0.060 |
Why?
|
| Tissue Survival | 1 | 2006 | 7 | 0.060 |
Why?
|
| Magnetics | 1 | 2006 | 32 | 0.060 |
Why?
|
| Anisotropy | 1 | 2006 | 117 | 0.060 |
Why?
|
| Rabbits | 2 | 2006 | 575 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 502 | 0.060 |
Why?
|
| Nasal Septum | 1 | 2006 | 27 | 0.060 |
Why?
|
| Child | 1 | 2026 | 26341 | 0.060 |
Why?
|
| Cartilage Diseases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 187 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 279 | 0.050 |
Why?
|
| Tomography, Optical | 1 | 2004 | 7 | 0.050 |
Why?
|
| Rhinoplasty | 1 | 2006 | 56 | 0.050 |
Why?
|
| Contrast Media | 1 | 2008 | 474 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2019 | 643 | 0.050 |
Why?
|
| Freezing | 1 | 2004 | 27 | 0.050 |
Why?
|
| Hair | 1 | 2004 | 30 | 0.050 |
Why?
|
| Fibrosis | 2 | 2016 | 429 | 0.050 |
Why?
|
| Acoustics | 1 | 2004 | 20 | 0.050 |
Why?
|
| Software | 2 | 2006 | 733 | 0.050 |
Why?
|
| Cryosurgery | 1 | 2004 | 51 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 178 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2003 | 50 | 0.050 |
Why?
|
| Intraocular Pressure | 2 | 2014 | 107 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 109 | 0.050 |
Why?
|
| Chorion | 1 | 2002 | 16 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2002 | 121 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 981 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2022 | 335 | 0.040 |
Why?
|
| Keratoconus | 1 | 2002 | 52 | 0.040 |
Why?
|
| Parathyroidectomy | 1 | 2021 | 51 | 0.040 |
Why?
|
| Calreticulin | 1 | 2021 | 23 | 0.040 |
Why?
|
| Corneal Topography | 1 | 2002 | 144 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2021 | 96 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2002 | 286 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3763 | 0.040 |
Why?
|
| Alloys | 1 | 2019 | 11 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2003 | 324 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2019 | 46 | 0.040 |
Why?
|
| Carbon | 1 | 2019 | 101 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4738 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3829 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 40 | 0.030 |
Why?
|
| Risk Factors | 2 | 2025 | 11074 | 0.030 |
Why?
|
| Walk Test | 1 | 2018 | 25 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 6459 | 0.030 |
Why?
|
| Europe | 1 | 2018 | 365 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 151 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 123 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 166 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 114 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 700 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 449 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6797 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2015 | 50 | 0.030 |
Why?
|
| Blood Physiological Phenomena | 1 | 2014 | 5 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 205 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1173 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 563 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 2014 | 17 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 688 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 304 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 84 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2014 | 450 | 0.020 |
Why?
|
| Supine Position | 1 | 2011 | 24 | 0.020 |
Why?
|
| Fixation, Ocular | 1 | 2011 | 19 | 0.020 |
Why?
|
| Blinking | 1 | 2011 | 28 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2010 | 32 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2885 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 928 | 0.020 |
Why?
|
| Solvents | 1 | 2010 | 39 | 0.020 |
Why?
|
| Photography | 1 | 2008 | 79 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1634 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2007 | 29 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 215 | 0.020 |
Why?
|
| Time | 1 | 2006 | 92 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2006 | 48 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2200 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 4886 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 824 | 0.010 |
Why?
|
| Thermography | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 362 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 81 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 39 | 0.010 |
Why?
|
| Biophysics | 1 | 2003 | 47 | 0.010 |
Why?
|
| Methacrylates | 1 | 2002 | 15 | 0.010 |
Why?
|
| Contact Lenses | 1 | 2002 | 39 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 450 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 826 | 0.010 |
Why?
|